COMMUNIQUÉS West-GlobeNewswire

Conditions financières améliorées de l'accord entre Nicox et Bausch + Lomb pour VYZULTA
14/03/2018
Communiqué de presse Conditions financières améliorées de l'accord entre Nicox et Bausch + Lomb pour VYZULTA TM Augmentation des redevances de 1% sur les ventes annuelles mondiales de VYZULTA TM dépassant 300 millions [...]
Nicox Announces Improved Financial Terms from Bausch + Lomb for VYZULTA
14/03/2018
Press Release Nicox Announces Improved Financial Terms from Bausch + Lomb for VYZULTA TM Increase in Royalties by 1% on Annual VYZULTA TM Global Sales Revenue Over $300 Million Additional $20 Million in Potential [...]
2017: Tecan with significant increase in sales and profit
14/03/2018
Financial results: full-year and second half of 2017 Order entry of CHF 564.1 million (2016: CHF 503.2 million) Full-year growth of 11.8% in local currencies or 12.1% in Swiss francs Double-digit growth rates in both [...]
Immuron Announces A$5.1M Private Placement to U.S. Fund
13/03/2018
MELBOURNE, Australia, March 13, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted [...]
BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development
13/03/2018
Pompano Beach, FL, March 13, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a focus in [...]
CORRECTING and REPLACING -- Intercept to Present at Upcoming Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ) please note that the conference date should be March 20, not [...]
Antares Pharma Provides Update Regarding the Cowen and Company 38th Annual Healthcare Conference
13/03/2018
EWING, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (the Company) today announced that due to the blizzard conditions and lack of travel options present in the greater Boston area, the [...]
Xeris Pharmaceuticals Announces a Formulation Development Collaboration with Asahi Kasei Pharma
13/03/2018
Chicago, March 13, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]
Vericel to Present at the 17th Annual Needham Healthcare Conference
13/03/2018
CAMBRIDGE, Mass., March 13, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]
Intercept to Present at Upcoming Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Sienna Senior Living Inc. Added to S&P/TSX Composite Index
13/03/2018
MARKHAM, Ontario, March 13, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) is pleased to announce that it will be added to the S&P/TSX Composite Index effective March [...]
Rockwell Medical, Inc. Appoints Two Independent and Experienced Life Sciences Executives to Board of Directors
13/03/2018
Lisa Colleran and Benjamin Wolin Unanimously Appointed to Rockwell Board Wolin Named Chairman of the Board Company Reaches Support Agreement with Richmond Brothers WIXOM, Mich., March 13, 2018 (GLOBE NEWSWIRE) -- [...]
Melinta Therapeutics Cancels Presentation at The Cowen & Company 38th Annual Health Care Conference Due to Inclement Weather
13/03/2018
NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]
ERYTECH to Webcast Presentation at the Cowen and Company 38th Annual Healthcare Conference
13/03/2018
ERYTECH to Webcast Presentation at the Cowen and Company 38 th Annual Healthcare Conference Lyon (France), March 13, 2018 - ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical [...]
Dyadic International to Announce Year End 2017 Financial Results and Host Conference Call on Tuesday March 27, 2018
13/03/2018
JUPITER, Fla., March 13, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help [...]
Teligent, Inc. to Present at the Oppenheimer 28th Annual Healthcare Conference on Tuesday March 20, 2018
13/03/2018
BUENA, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Oppenheimer 28 th Annual Healthcare Conference. The [...]
Auris Medical Provides Business Update
13/03/2018
Zug, Switzerland, March 13, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today provided an [...]
SELLAS Life Sciences to Present at the Oppenheimer 28th Annual Healthcare Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]
Coherus BioSciences Announces New Employment Inducement Grants
13/03/2018
REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that effective March 12, 2018, the compensation committee of the company’s board of directors granted 2 [...]

Pages